What Comes After Merck’s Keytruda? The Race for the Next Standard Cancer Treatment.

Summary

Article discusses the competitive landscape following Merck's Keytruda franchise, examining potential successor therapies in oncology. No specific clinical data, regulatory decisions, or financial information is provided in the article excerpt.